Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tremfya (guselkumab)
Pharma
J&J pads Tremfya IBD offerings with subQ ulcerative colitis nod
With a fresh FDA nod, J&J has rounded out Tremfya’s presence in inflammatory bowel disease and achieved a first for the IL-23 inhibitor drug class.
Fraiser Kansteiner
Sep 22, 2025 11:01am
AbbVie's Skyrizi, Rinvoq led TV drug ad spending again in August
Sep 5, 2025 6:50am
TV drug ad spending plummeted 20% in July
Aug 5, 2025 11:40am
J&J logs strong innovative drug sales despite Stelara's decline
Jul 16, 2025 11:19am
Novo’s Wegovy retakes top TV spending spot in June
Jul 7, 2025 12:42pm
The top 10 pharma drug ad spenders of 2024
Jun 30, 2025 3:00am
